A Review on Topical Drug Delivery System: Proniosomal Powder of Flurbiprofen
Abstract
Full Text:
PDFReferences
Perrett S, Golding M, Williams WP. A Simple Method for Preparing Liposomes for Pharmaceutical Applications: Characterization of the Liposomes. J. Pharm. Pharmacol. 1991, 43, 154–161.
Verma S, Singh S. K, Mathur Pooja. Nanoparticular vesicular system: a versatile tool for drug delivery. J. Chem. pharm. Res.2010; 2 (2): 496–509.
Abubakar N.O. Recent progress in sustained/controlled l delivery of captopril. Int. J. Pharm.2000; 194: 139–146.
Sudha Mani. T, Priyadarshini N, Radhakrishnan M, promising drug carrier’s proniosomes. ResearchInternational Journal of PharmTech 2010; 2 (2): 1446–1454.
Chengjiu Hu, Rode’s D.G, proniosomes. A novel drug carrier preparation. International journal of pharmaceutics.1999; 185: 23–35.
A Review on Topical Drug Delivery System: Proniosomal Powder of Flurbiprofen Tripathi et al. © JournalsPub 2022. All Rights Reserved 31
Almira I, Blazek W, Rhodes D.G. SEM imaging predicts quality of niosomes from maltodextrinbased proteasome. Pharmaceutical Research. 200; 18 (5): 656–661.
Agrawal R, Katare O.P, Vyas S.P. Preparation and in-vitro evaluation of liposome/liposomal delivery system for ant psoriatic drug dithranol. Int. J. Pharm. 2001; 18 (5): 656–661.
Annakula Deepthi, Rao Madhukar Errabelli, Jukanti Raju. Provesticlular drug delivery’s system: an overview and appraisal. Scholars research library. 2010; 2 (4): 135–146.
Jain N. K. “Controlled and novel drug delivery 1st edition (1997) 101–106
Nasr Mohamed. In-Vitro and In-Vivo Evaluation of Proniosomes Containing Celecoxib for Oral Administration. AAPS Pharm SciTech, 2010; 11 (1) 85–89.
Rathi V. Formulation and evaluation of maltodextrin based proteosome loaded with indomethacin. International journal of pharmtech research. 2009; 1 (3): 517–523.
Tank C.J, Borkhataria Chetan H, B. Ashok H. Formulation and evaluation of Aceclofenac loaded maltodextrin based proniosomes. Int. J. Chem Tech Res. 2009; 1 (3): 567–573.
Sharma P.K., Chandra A. Proniosome based drug delivery system of piroxicam. African Journal of pharmacy and pharmacology.2008; 2 (9): 184–190.
Tripathi K.D. “Essentials of medical pharmacology”; Fifth edition; Jaypee brothers. medical publishers (p) Ltd. New Delhi, pp., 725, 730–731.
Gupta A, Prajapati S. K, Balamurugan M, Singh M, Bhatia D. Design and development of proniosomal transdermal drug delivery systems for captopril. Trop J Pharm Res. 2007; 6: 687–693.
Ibrahim A. Alsarra A.A. Proniosomes as a drug carrier for transdermal delivery of ketorolac. European Journal of pharmaceutics and biopharmaceutics. 2005; 59: 485–490.
Agarwal D, Pal D, Mitra A.K, and Kaur I.P. Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation humour. Int J Pharm. 2007; 338: 21–26.
Blazek-Welsh, Almere I. SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes. Pharmaceuticals research. 2001; 18:5.
Yadav N.K, Saroha Kamal, Proniosome gel: potential carrier system in topical/transdermal delivery for drugs and cosmetic/cosmeceuticals. Adv Drug Deliv. Rev. 2002; 54 (1) s131-s155.
Fang J.Y, Hwang T.L, Huang Y.L, Fang C.L. Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactant and ethanol, Int. J. Pharm. 310 (2006) 131–138.
Refbacks
- There are currently no refbacks.